ARTICLE | Company News
Trinity, Xtrana deal
November 19, 2001 8:00 AM UTC
Diagnostics developer TRIB will acquire XTRN's hemostasis business for $6.3 million in cash and notes. The division includes test kits for blood coagulation, thrombotic risk factors, fibrinolysis, pla...